TUBEROUS SCLEROSIS COMPLEX
Clinical trials for TUBEROUS SCLEROSIS COMPLEX explained in plain language.
Never miss a new study
Get alerted when new TUBEROUS SCLEROSIS COMPLEX trials appear
Sign up with your email to follow new studies for TUBEROUS SCLEROSIS COMPLEX, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
10-Year safety watch for seizure drug in rare genetic disorder
Disease control OngoingThis study follows patients with tuberous sclerosis complex (TSC) who have seizures that are hard to control with standard medications. It monitors the long-term safety of the drug everolimus over approximately 10 years in about 206 patients who benefited from it in a previous tr…
Matched conditions: TUBEROUS SCLEROSIS COMPLEX
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Safety check: does a seizure drug harm the liver over time?
Disease control OngoingThis study aims to monitor the long-term safety of Epidiolex (cannabidiol), a prescription medication for severe seizure disorders. It will check if long-term use causes chronic liver injury or scarring in 154 participants who are already taking or starting the drug. The main goa…
Matched conditions: TUBEROUS SCLEROSIS COMPLEX
Phase: PHASE4 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
New scan could give early clues for rare lung disease treatment
Knowledge-focused OngoingThis study is testing whether a special type of PET scan can show early signs that a drug called rapamycin is working in patients with a rare lung disease called LAM. Researchers want to see if the scan can detect changes in tumor metabolism before other tests show improvement. A…
Matched conditions: TUBEROUS SCLEROSIS COMPLEX
Phase: PHASE1, PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Mar 17, 2026 12:55 UTC